12:00 AM
 | 
Aug 24, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Aptocine talaporfin sodium: Phase II started

Light Sciences began a single-arm, open-label, Australian and New Zealand Phase II trial to evaluate 1 mg/kg IV Aptocine followed by 100 J/cm of...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >